Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K G Parhofer

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
MMW Fortschritte Der Medizin|March 20, 2019
K G Parhofer
MMW Fortschritte Der Medizin|April 6, 2020
K G Parhofer
Herz|March 11, 2016
[PCSK9 inhibitors in hypercholesterolemia. New hope for patients with diabetes mellitus?]K G Parhofer
MMW Fortschritte Der Medizin|September 9, 2019
K G Parhofer
MMW Fortschritte Der Medizin|February 24, 2001
[Primary prevention in atherosclerosis. Properly assessing the risk of your patient]K G Parhofer, P Schwandt
MMW Fortschritte Der Medizin|November 9, 2002
[Glinides and glitazones in diabetes treatment. Are they really effective?]K G Parhofer, B Göke
Der Internist|December 16, 2003
[Therapy of hyperlipoproteinemia in the elderly]K G Parhofer, B Göke
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 19, 2007
Liquid chromatography tandem-mass spectrometry (LC-MS/MS)--technique and applications in endocrinologyM Vogeser, K G Parhofer
Metabolism: Clinical and Experimental|April 29, 1998
Low-density lipoprotein-apolipoprotein B metabolism following apheresis: simulation studies of mass changes and tracer kineticsP H Barrett, K G Parhofer
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|August 20, 2003
Extracorporal low-density lipoprotein elimination by immunoadsorptionM M Ritter, K G Parhofer
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
MMW Fortschritte Der Medizin|March 20, 2019
K G Parhofer
MMW Fortschritte Der Medizin|April 6, 2020
K G Parhofer
Herz|March 11, 2016
[PCSK9 inhibitors in hypercholesterolemia. New hope for patients with diabetes mellitus?]K G Parhofer
MMW Fortschritte Der Medizin|September 9, 2019
K G Parhofer
MMW Fortschritte Der Medizin|February 24, 2001
[Primary prevention in atherosclerosis. Properly assessing the risk of your patient]K G Parhofer, P Schwandt
MMW Fortschritte Der Medizin|November 9, 2002
[Glinides and glitazones in diabetes treatment. Are they really effective?]K G Parhofer, B Göke
Der Internist|December 16, 2003
[Therapy of hyperlipoproteinemia in the elderly]K G Parhofer, B Göke
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 19, 2007
Liquid chromatography tandem-mass spectrometry (LC-MS/MS)--technique and applications in endocrinologyM Vogeser, K G Parhofer
Metabolism: Clinical and Experimental|April 29, 1998
Low-density lipoprotein-apolipoprotein B metabolism following apheresis: simulation studies of mass changes and tracer kineticsP H Barrett, K G Parhofer
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|August 20, 2003
Extracorporal low-density lipoprotein elimination by immunoadsorptionM M Ritter, K G Parhofer
Pageof 10